Thrombocytopenia After Gemtuzumab Is Reversible by Intravenous Immunoglobulin
Leukemia - United Kingdom
doi 10.1038/sj.leu.2403757
Full Text
Open PDFAbstract
Available in full text
Date
April 7, 2005
Authors
Publisher
Springer Science and Business Media LLC